Melphalan and whole-blood stem cell reinfusion in castration-resistant prostate cancer (CRPC): A phase I/II study.

被引：0
|
作者：
Shamash, J.
Jacob, J.
Powles, T.
Agrawal, S.
Mutsvangwa, K.
Saunders, N.
Wilson, P.
Stebbing, J.
机构：
[1] St Bartholomews Hosp, London, England
[2] Univ London Imperial Coll Sci Technol & Med, London, England
[3] St Barthlomews Hosp, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.2573
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2573
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II Study with metastatic castration-resistant Prostate Cancer (mCRPC) Patients
    Rexer, H.
    Graefen, M.
    UROLOGE, 2017, 56 (11): : 1468 - 1470
  • [32] Phase II Study of Dasatinib in Patients with Metastatic Castration-Resistant Prostate Cancer
    Yu, Evan Y.
    Wilding, George
    Posadas, Edwin
    Gross, Mitchell
    Culine, Stephane
    Massard, Christophe
    Morris, Michael J.
    Hudes, Gary
    Calabro, Fabio
    Cheng, Shinta
    Trudel, Geralyn C.
    Paliwal, Prashni
    Sternberg, Cora N.
    CLINICAL CANCER RESEARCH, 2009, 15 (23) : 7421 - 7428
  • [33] Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Danila, Daniel Costin
    Anand, Aseem
    Heller, Glenn
    Wan, Mingliang
    Herkal, Amrita
    Patel, Chintan
    Khanin, Raya
    Schultz, Nikolaus
    Lilja, Hans
    Fleisher, Martin
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [34] Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer
    Masahiro Nozawa
    Hirofumi Mukai
    Shunji Takahashi
    Hiroji Uemura
    Takeo Kosaka
    Yusuke Onozawa
    Jun Miyazaki
    Kazuhiro Suzuki
    Koji Okihara
    Yoichi Arai
    Tomomi Kamba
    Masashi Kato
    Yasutomo Nakai
    Hiroshi Furuse
    Haruki Kume
    Hisamitsu Ide
    Hiroshi Kitamura
    Akira Yokomizo
    Takahiro Kimura
    Yoshihiko Tomita
    Keiji Ohno
    Yoshiyuki Kakehi
    International Journal of Clinical Oncology, 2015, 20 : 1026 - 1034
  • [35] A Phase I Study of Everolimus and Docetaxel in Patients With Castration-Resistant Prostate Cancer
    Courtney, Kevin D.
    Manola, Judith B.
    Elfiky, Aymen A.
    Ross, Robert
    Oh, William K.
    Yap, Jeffrey T.
    Van den Abbeele, Annick D.
    Ryan, Christopher W.
    Beer, Tomasz M.
    Loda, Massimo
    Priolo, Carmen
    Kantoff, Philip
    Taplin, Mary-Ellen
    CLINICAL GENITOURINARY CANCER, 2015, 13 (02) : 113 - 123
  • [36] Japanese phase I study of cabazitaxel in metastatic castration-resistant prostate cancer
    Nozawa, Masahiro
    Mukai, Hirofumi
    Takahashi, Shunji
    Uemura, Hiroji
    Kosaka, Takeo
    Onozawa, Yusuke
    Miyazaki, Jun
    Suzuki, Kazuhiro
    Okihara, Koji
    Arai, Yoichi
    Kamba, Tomomi
    Kato, Masashi
    Nakai, Yasutomo
    Furuse, Hiroshi
    Kume, Haruki
    Ide, Hisamitsu
    Kitamura, Hiroshi
    Yokomizo, Akira
    Kimura, Takahiro
    Tomita, Yoshihiko
    Ohno, Keiji
    Kakehi, Yoshiyuki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (05) : 1026 - 1034
  • [37] A Phase I-II Study of Docetaxel and Atrasentan in Men with Castration-Resistant Metastatic Prostate Cancer
    Armstrong, Andrew J.
    Creel, Patricia
    Turnbull, James
    Moore, Cassandra
    Jaffe, Tracy A.
    Haley, Sherri
    Petros, William
    Yenser, Sarah
    Gockerman, Jon P.
    Sleep, Darryl
    Hurwitz, Herbert
    George, Daniel J.
    CLINICAL CANCER RESEARCH, 2008, 14 (19) : 6270 - 6276
  • [38] CLINICAL STUDY OF MDV3100 IN PROGRESSIVE CASTRATION-RESISTANT PROSTATE CANCER (CRPC)
    Scher, Howard I.
    Beer, Tomasz
    Higano, Celestia
    Efstathiou, Eleni
    Anand, Aseem
    Hirmand, Mohammad
    Hung, David
    Steve, Larson
    Fleisher, Martin
    Sawyers, Charles
    JOURNAL OF UROLOGY, 2009, 181 (04): : 230 - 230
  • [39] Everolimus plus bicalutamide in men with castration-resistant prostate cancer (CRPC): Final results of a phase II trial.
    Pan, Chong-xian
    Chow, Helen
    Ghosh, Paramita
    White, Ralph deVere
    Evans, Christopher P.
    Dall'Era, Marc A.
    Yap, Stanley A.
    Li, Judy
    Beckett, Laurel A.
    Lara, Primo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [40] Sargramostim (GM-CSF) and lenalidomide in castration-resistant prostate cancer (CRPC): Results from a phase I-II clinical trial
    Garcia, Jorge A.
    Elson, Paul
    Tyler, Allison
    Triozzi, Pierre
    Dreicer, Robert
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 33.e11 - 33.e17
12345